Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Does a seasonal flu shot raise the risk of swine flu?

Four new studies by Canadian researchers have come up with the result that the traditional seasonal flu vaccine that has been used for some time now is related to an increased risk of infection with pandemic H1N1 swine flu.

7 Apr 2010

Sinovac Biotech's fourth-quarter sales increase 194%

Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today its unaudited financial results for the three-month and preliminary twelve-month periods ended December 31, 2009.

6 Apr 2010

Health officials monitor cases of pandemic H1N1 flu in the Southeast

The continued spread of H1N1 influenza virus this spring is cause to pay heed to upper-respiratory maladies such as congestion, runny nose and cough, says David Kimberlin, M.D., a preeminent influenza specialist who co-directs the University of Alabama at Birmingham (UAB) Division of Pediatric Infectious Diseases.

6 Apr 2010

Premature fall in the swine flu vaccination rates worries health officials

Last fall there was a mad rush for the HINI vaccine for the deadly swine flu that had gripped countries across the world. H1N1 flu has killed about 12,000 Americans and put 265,000 into the hospital in the last pandemic. This year has seen a few signs of seasonal flu, which kills about 36,000 people in the United States each year and puts 200,000 in the hospital.

2 Apr 2010

Utilizing "synthetic population" in simulating spread of infectious outbreaks

Did you know that filling out your census card will help computer scientists model how diseases spread in the United States?

2 Apr 2010

2010 Internal Medicine conference at Toronto Convention Center

More than 5,000 internists (adult medicine specialists), subspecialists, medical students, and allied health professionals will meet in Toronto, Canada, for Internal Medicine 2010, the annual scientific meeting of the American College of Physicians (ACP), April 22 - 24 (Thursday - Saturday), at the Toronto Convention Center.

2 Apr 2010

2010 BIO International Convention to discuss issues that impact drug discovery and development

The 2010 BIO International Convention will feature a robust health and medical program highlighting the latest scientific breakthroughs and policy and business development issues that impact drug discovery and development. Hosted by the Biotechnology Industry Organization, the Convention will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.

31 Mar 2010

CDC, Surgeon General report on increased number of H1N1 cases in southeast U.S.

Although H1N1 (swine flu) "has waned across much of the United States, the southeast is reporting an increase in cases of the H1N1 virus, U.S. health officials said on Monday," Reuters reports.

31 Mar 2010

First Edition: March 30, 2010

Today's news pages are full of stories detailing more particulars of the new health care bill to be signed into law today by President Obama. Meanwhile, the headlines also indicate that for Democrats, politically capitalizing on the new measure will be no easy task.

30 Mar 2010

Emory Institute of Drug Discovery and Zirus collaborate to develop new anti-viral drugs

The Emory Institute of Drug Discovery and Zirus, Inc., a biotechnology company based in Buford, Georgia, have entered into a collaboration and research agreement to develop novel compounds to treat infectious disease. Zirus uses a proprietary method for identifying genes and gene products in host cells that, when blocked, can prevent viruses from multiplying. Over the past several years, either alone or in collaboration with partners, including the Centers for Disease Control and Prevention (CDC), Zirus has identified, licensed and filed patents on more than 1000 targets.

30 Mar 2010

Preclinical study of DAS181 for treatment and prevention of ILI published

NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.

30 Mar 2010

Parenteral Biotech to supply and distribute Sinovac Biotech's Anflu and PANFLU.1 vaccines in India

Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today it has entered into exclusive license, supply and distribution agreements with Parenteral Biotech Ltd., a subsidiary of Parenteral Drugs (India), Ltd., an India-based pharmaceutical company. Pursuant to the agreements, Parenteral is authorized to register, supply and distribute Sinovac's Anflu (seasonal influenza vaccine) and PANFLU.1 (H1N1 vaccine) to the government of India and private market in India. Currently, the registration process is ongoing in India.

29 Mar 2010

Inovio Biomedical's total revenue increased to $2.6M for quarter ended December 31, 2009

Inovio Biomedical Corporation today reported financial results for the quarter and year ended December 31, 2009.

29 Mar 2010

Antiviral treatment may lead to drug-resistant H1N1 virus: NIAID

Two people with compromised immune systems who became ill with 2009 H1N1 influenza developed drug-resistant strains of virus after less than two weeks on therapy, report doctors from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

27 Mar 2010

New ways to halt the rise of antimicrobial-resistant infections

Preventing, controlling and treating drug-resistant infections is one of the major challenges in modern medicine. Antimicrobial Resistance goes beyond simple definitions and microbiological data to fully explore this rapidly changing area, describing evidence for effective interventions, costs, treatment strategies and directions for future research.

27 Mar 2010

Increasing spread of HIV/STD disease among MSM in Africa and Asia

Increasing rate of HIV/STD disease is being reported among 'men who have sex with men' with high risk behaviors in Africa and Asia, according to a groundbreaking paper in the April issue of Sexually Transmitted Diseases, official journal of the American Sexually Transmitted Diseases Association.

27 Mar 2010

Senate briefing to discuss TB and drug-resistant TB

A Senate briefing today will discuss TB and drug-resistant TB, including multidrug-resistant TB (MDR-TB) and extensively drug resistant (XDR-TB), the impact on global health and the current state of surveillance, diagnosis and treatment around the world.

26 Mar 2010

Positive results from Stage A pivotal study of 2009 A/H1N1 VLP pandemic influenza vaccine

Novavax, Inc. announced today positive results from the entire 1,000 subject Stage A of its two-stage pivotal study evaluating the safety and immunogenicity of Novavax's unadjuvanted 2009 A/H1N1 virus-like particle pandemic influenza vaccine.

26 Mar 2010

IMDx 2009 Influenza A H1N1 Real-Time RT-PCR Assay granted EUA from FDA

IMDx announced today that its IMDx 2009 Influenza A H1N1 Real-Time RT-PCR Assay has been granted Emergency Use Authorization from the U.S. Food and Drug Administration.

26 Mar 2010

Innovation holds the key for solving healthcare's dilemmas, says Eli Lilly

In an address to the American Chamber of Commerce in Germany today, John C. Lechleiter, Ph.D., chairman, president and chief executive officer of Eli Lilly and Company, said that innovation holds the key to solving one of healthcare's thorniest dilemmas: how to improve quality and access while controlling costs.

25 Mar 2010

Pandemic News and Research

Further Reading

Does a seasonal flu shot raise the risk of swine flu?

Sinovac Biotech's fourth-quarter sales increase 194%

Health officials monitor cases of pandemic H1N1 flu in the Southeast

Premature fall in the swine flu vaccination rates worries health officials

Utilizing "synthetic population" in simulating spread of infectious outbreaks

2010 Internal Medicine conference at Toronto Convention Center

2010 BIO International Convention to discuss issues that impact drug discovery and development

CDC, Surgeon General report on increased number of H1N1 cases in southeast U.S.

First Edition: March 30, 2010

Emory Institute of Drug Discovery and Zirus collaborate to develop new anti-viral drugs

Preclinical study of DAS181 for treatment and prevention of ILI published

Parenteral Biotech to supply and distribute Sinovac Biotech's Anflu and PANFLU.1 vaccines in India

Inovio Biomedical's total revenue increased to $2.6M for quarter ended December 31, 2009

Antiviral treatment may lead to drug-resistant H1N1 virus: NIAID

New ways to halt the rise of antimicrobial-resistant infections

Increasing spread of HIV/STD disease among MSM in Africa and Asia

Senate briefing to discuss TB and drug-resistant TB

Positive results from Stage A pivotal study of 2009 A/H1N1 VLP pandemic influenza vaccine

IMDx 2009 Influenza A H1N1 Real-Time RT-PCR Assay granted EUA from FDA

Innovation holds the key for solving healthcare's dilemmas, says Eli Lilly

Best practices - optimize qPCR processes for pathogen detection eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News